Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The epidemiology of amyotrophic lateral sclerosis
Evelyn O. Talbott, Angela M. Malek, David Lacomis
Handbook of clinical neurology (2016), pp. 225-238
Closed Access | Times Cited: 304

Showing 1-25 of 304 citing articles:

Ageing as a risk factor for neurodegenerative disease
Yujun Hou, Xiuli Dan, Mansi Babbar, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 10, pp. 565-581
Closed Access | Times Cited: 2410
Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications
Ruth Chia, Adriano Chiò, Bryan J. Traynor
The Lancet Neurology (2017) Vol. 17, Iss. 1, pp. 94-102
Open Access | Times Cited: 505
Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies
Hasnaa A. Elfawy, Biswadeep Das
Life Sciences (2018) Vol. 218, pp. 165-184
Closed Access | Times Cited: 290
Epidemiology of paraneoplastic neurological syndromes: a population-based study
Alberto Vogrig, Gian Luigi Gigli, Samantha Segatti, et al.
Journal of Neurology (2019) Vol. 267, Iss. 1, pp. 26-35
Closed Access | Times Cited: 151
iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders
Hideyuki Okano, Satoru Morimoto
Cell stem cell (2022) Vol. 29, Iss. 2, pp. 189-208
Open Access | Times Cited: 122
Mitochondrial dysfunction in neurodegenerative disorders
Madelyn Klemmensen, Seth H. Borrowman, Colin Pearce, et al.
Neurotherapeutics (2023) Vol. 21, Iss. 1, pp. e00292-e00292
Open Access | Times Cited: 81
Targeting the “hallmarks of aging” to slow aging and treat age-related disease: fact or fiction?
Maryam Keshavarz, Kan Xie, Kristina Schaaf, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 242-255
Open Access | Times Cited: 74
Current State and Future Directions in the Therapy of ALS
Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1523-1523
Open Access | Times Cited: 58
Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine
Shuai Jin, Lijuan Zhang, Lin Wang
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115215-115215
Open Access | Times Cited: 58
Neuropathogenesis-on-chips for neurodegenerative diseases
Sarnai Amartumur, Huong Mai Nguyen, Thuy Huynh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 32
Modulation of Mitochondria–Endoplasmic Reticulum Contacts (MERCs) by Small Molecules as a New Strategy for Restoring Lipid Metabolism in an Amyotrophic Lateral Sclerosis Model
Mikel Etxebeste-Mitxeltorena, Hector Flores‐Romero, Sandra Ramos-Inza, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 3
The role of mitochondrial remodeling in neurodegenerative diseases
Duanqin Guan, Congmin Liang, Dongyan Zheng, et al.
Neurochemistry International (2025), pp. 105927-105927
Closed Access | Times Cited: 2
Advancements in genetic research and RNA therapy strategies for amyotrophic lateral sclerosis (ALS): current progress and future prospects
Paola Ruffo, Bryan J. Traynor, F. L. Conforti
Journal of Neurology (2025) Vol. 272, Iss. 3
Open Access | Times Cited: 2
Mercury Involvement in Neuronal Damage and in Neurodegenerative Diseases
Veronica Lanza Cariccio, Annalisa Samà, Placido Bramanti, et al.
Biological Trace Element Research (2018) Vol. 187, Iss. 2, pp. 341-356
Closed Access | Times Cited: 162
FUS pathology in ALS is linked to alterations in multiple ALS-associated proteins and rescued by drugs stimulating autophagy
Lara Marrone, Hannes C. A. Drexler, Jie Wang, et al.
Acta Neuropathologica (2019) Vol. 138, Iss. 1, pp. 67-84
Open Access | Times Cited: 105
Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin
Benôıt Marin, Giancarlo Logroscino, Farid Boumédiène, et al.
European Journal of Epidemiology (2015) Vol. 31, Iss. 3, pp. 229-245
Closed Access | Times Cited: 97
Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis
Valentina Cappello, Maura Francolini
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 10, pp. 2092-2092
Open Access | Times Cited: 95
Competing Endogenous RNA Networks as Biomarkers in Neurodegenerative Diseases
Leticia Moreno‐García, Tresa López‐Royo, Ana Cristina Calvo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9582-9582
Open Access | Times Cited: 95
Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017
Paul Mehta, Jaime Raymond, Reshma Punjani, et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2022) Vol. 24, Iss. 1-2, pp. 108-116
Open Access | Times Cited: 54
The role of inflammation in neurodegeneration: novel insights into the role of the immune system in C9orf72 HRE-mediated ALS/FTD
Pegah Masrori, Jimmy Beckers, Helena Gossye, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 46
Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection
Sun Hyung Joo, Kiyoung Kim
Antioxidants (2022) Vol. 11, Iss. 2, pp. 195-195
Open Access | Times Cited: 45
MicroRNA-21 Is a Versatile Regulator and Potential Treatment Target in Central Nervous System Disorders
Xue Bai, Zhigang Bian
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 45
Genetically modified non-human primate models for research on neurodegenerative diseases
Ming-Tian Pan, Han Zhang, Xiao‐Jiang Li, et al.
动物学研究 (2024) Vol. 45, Iss. 2, pp. 263-274
Open Access | Times Cited: 11
Antisense Oligonucleotides (ASOs) in Motor Neuron Diseases: A Road to Cure in Light and Shade
Silvia Cantara, Giorgia Simoncelli, Claudia Ricci
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4809-4809
Open Access | Times Cited: 11
Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches
Gökhan Burçin Kubat, Pasquale Picone
Neurological Sciences (2024) Vol. 45, Iss. 9, pp. 4121-4131
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top